Quantitative analysis of intact glycosaminoglycans in cerebrospinal fluid of stroke patient using LC-Q-TOF MS coupled with the MSALL technique

Glycosaminoglycans (GAGs), linear polysaccharides with varying degrees of sulfation, are key structural components of the endothelial glycocalyx. The endothelial glycocalyx helps maintain the integrity of the blood-brain barrier (BBB); however, its degradation or shedding contributes to BBB dysfunction. Understanding the relationship between GAG levels and BBB dysfunction requires a robust, high-throughput strategy for GAG quantification. In previous studies using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS), GAGs were typically enzymatically or chemically depolymerized into disaccharides before analysis. Intact GAGs are characterized by heterogeneous molecular weights, diverse sulfation patterns, and multiple charge states, making direct MS analysis challenging. To overcome these challenges, we employed a MS<sup>ALL</sup>-based liquid chromatography-triple-quadrupole/time-of-flight mass spectrometry (LC-Q-TOF MS) technique. To our knowledge, this is the first quantification of intact GAGs by LC-MS/MS without chemical or enzymatic digestion. Additionally, a unique sample preparation method, involving concentration followed by phenol and dichloromethane extraction, was developed to overcome the electrostatic interactions between GAGs and proteins. Method validation demonstrated a linear detection range for GAGs at concentrations of 50-5000 ng/mL with limit of detection (LOD) of 20 ng/mL and lower limit of quantification (LLOQ) of 50 ng/mL. As a proof of principle, analysis of CSF from 83 stroke patients and 42 control subjects revealed elevated GAG levels in the stroke group, corresponding to 83.13% specificity and 76.19% sensitivity in distinguishing stroke-induced BBB dysfunction from controls. These findings suggest that GAG quantification can serve as an effective measure of glycocalyx shedding and that GAG may represent a potential biomarker for BBB dysfunction.

Authors

Institutions

Publication Details

Journal
Talanta
Published
2026-03-11
DOI
https://doi.org/10.1016/j.talanta.2026.129664
Primary Topic
Trauma, Hemostasis, Coagulopathy, Resuscitation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantitative analysis of intact glycosaminoglycans in cerebrospinal fluid of stroke patient using LC-Q-TOF MS coupled with the MSALL technique

Wenbo Ren, Haiwei Cao, Yina Pan, Xue Du et al.
Talanta
Trauma, Hemostasis, Coagulopathy, Resuscitation
article

Quantitative analysis of intact glycosaminoglycans in cerebrospinal fluid of stroke patient using LC-Q-TOF MS coupled with the MSALL technique

Wenbo Ren, Haiwei Cao, Yina Pan, Xue Du, jiancheng xu, Tingting Wang
article en

Abstract

Glycosaminoglycans (GAGs), linear polysaccharides with varying degrees of sulfation, are key structural components of the endothelial glycocalyx. The endothelial glycocalyx helps maintain the integrity of the blood-brain barrier (BBB); however, its degradation or shedding contributes to BBB dysfunction. Understanding the relationship between GAG levels and BBB dysfunction requires a robust, high-throughput strategy for GAG quantification. In previous studies using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS), GAGs were typically enzymatically or chemically depolymerized into disaccharides before analysis. Intact GAGs are characterized by heterogeneous molecular weights, diverse sulfation patterns, and multiple charge states, making direct MS analysis challenging. To overcome these challenges, we employed a MS<sup>ALL</sup>-based liquid chromatography-triple-quadrupole/time-of-flight mass spectrometry (LC-Q-TOF MS) technique. To our knowledge, this is the first quantification of intact GAGs by LC-MS/MS without chemical or enzymatic digestion. Additionally, a unique sample preparation method, involving concentration followed by phenol and dichloromethane extraction, was developed to overcome the electrostatic interactions between GAGs and proteins. Method validation demonstrated a linear detection range for GAGs at concentrations of 50-5000 ng/mL with limit of detection (LOD) of 20 ng/mL and lower limit of quantification (LLOQ) of 50 ng/mL. As a proof of principle, analysis of CSF from 83 stroke patients and 42 control subjects revealed elevated GAG levels in the stroke group, corresponding to 83.13% specificity and 76.19% sensitivity in distinguishing stroke-induced BBB dysfunction from controls. These findings suggest that GAG quantification can serve as an effective measure of glycocalyx shedding and that GAG may represent a potential biomarker for BBB dysfunction.

TalantaVol. 305
Jilin University (CN), First Hospital of Jilin University (CN)
Openalex Percentile: Top 28%
Trauma, Hemostasis, Coagulopathy, Resuscitation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.